The podocyte cytoskeleton in health and in disease

Clinical Kidney Journal

Volumn 5, Issue 6, 2012, Pages 498-501

  Mathieson, Peter W ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

actin; cytoskeleton; podocyte; proteinuria

Indexed keywords

ALPHA ACTININ 4; CALCINEURIN; CALCIUM SENSING RECEPTOR; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; GLITAZONE DERIVATIVE; MUTANT PROTEIN; PROTEIN CDC42; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SYNAPTOPODIN; TUMOR NECROSIS FACTOR ALPHA;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ARHGAP24 GENE; CELL FUNCTION; CELL REGENERATION; CELL RENEWAL; CELL SHAPE; CELL SIZE; CYTOARCHITECTURE; CYTOPLASM; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FOCAL GLOMERULOSCLEROSIS; GENE; GENE MUTATION; GENETIC TRANSCRIPTION; GLOMERULUS CAPILLARY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; MICROTUBULE; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEINURIA; REVIEW; T LYMPHOCYTE;

EID: 84870560266     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfs153     Document Type: Review

References (27)

1. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081
2. Jim B, Santos J, Spath F et al. Biomarkers of diabetic nephropathy, the present and the future. Curr Diabetes Rev 2012; 8: 317-328
3. D'Agati VD. Pathobiology of focal segmental glomerulosclerosis: new developments. Curr Opin Nephrol Hypertens 2012; 21: 243-250
4. Mathieson PW. The podocyte as a target for therapies-new and old. Nat Rev Nephrol 2011; 8: 52-56
5. Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 2010; 25: 1621-1632
6. Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24: 251-256 (Pubitemid 30132192)
7. Pollak MR. Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol 2002; 13: 3016-3023 (Pubitemid 35386922)
8. Michaud JL, Lemieux LI, Dubé M et al. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J Am Soc Nephrol 2003; 14: 1200-1211 (Pubitemid 36514662)
9. Yao J, Le TC, Kos CH et al. Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol 2004; 2: e167
10. Weins A, Schlondorff JS, Nakamura F et al. Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinity. Proc Natl Acad Sci USA 2007; 104: 16080-16085 (Pubitemid 350099367)
11. Ward SM, Weins A, Pollak MR et al. Dynamic viscoelasticity of actin cross-linked with wild-type and disease-causing mutant alpha-actinin-4. Biophys J 2008; 95: 4915-4923
12. Khurana S, Chakraborty S, Lam M et al. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. J Biol Chem2012; 287: 12027-12035
13. Shih NY, Li J, Karpitskii V et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999; 286: 312-315 (Pubitemid 29484698)
14. Tan R, Patni H, Tandon P et al. Nef interaction with actin compromises human podocyte actin cytoskeletal integrity. Exp Mol Pathol 2012; doi:10.1016/j.yexmp.2012.06.001
15. Faul C, Donnelly M, Merscher-Gomez S et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008; 14: 931-938
16. Mathieson PW. Clinical implications of basic research: proteinuria and immunity-an over-stated relationship?. New Engl J Med 2008; 359: 2492-2494
17. Xing CY, Saleem MA, Coward RJ et al. Direct effects of dexamethasone on human podocytes. Kidney Int 2006; 70: 1038-1045 (Pubitemid 44344073)
18. Liu H, Gao X, Xu H et al. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury. Nephrology (Carlton) 2012; 17: 669-675
19. Agrawal S, Guess AJ, Benndorf R et al. Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects. Mol Pharmacol 2011; 80: 389-399
20. Zhu L, Jiang R, Aoudjit L et al. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011; 22: 1621-1630
21. Wang L, Ellis MJ, Gomez JA et al. Mechanisms of the proteinuria induced by Rho GTPases. Kidney Int 2012; 81: 1075-1085
22. Meyer-Schwesinger C, Dehde S, Sachs M et al. Rho-kinase inhibition prevents proteinuria in immune-complex mediated anti-podocyte nephritis. Am J Physiol Renal Physiol 2012; 303: F1015-F1025
23. Scott RP, Hawley SP, Ruston J et al. Podocyte-specific loss of cdc42 leads to congenital nephropathy. J Am Soc Nephrol 2012; 23: 1149-1154
24. Akilesh S, Suleiman H, Yu H et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J Clin Invest 2011; 121: 4127-4137
25. Bitzan M, Babayeva S, Vasudevan A et al. TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation. Pediatr Nephrol 2012; 27: 2217-2226
26. Oh J, Beckmann J, Bloch J et al. Stimulation of the calciumsensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis. Kidney Int 2011; 80: 483-492
27. Swärd P, Rippe B. Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability. Acta Physiol (Oxf) 2012; 204: 294-307